Search Term:

*


January 16, 2018: Product identified by key industry publication as one of the most exciting commercial drug development and manufacturing technologies, tools or services released during the past year

February 27, 2018: New offices, labs and manufacturing space for development and optimization of customer processes

September 3, 2018: Celltheon and Pall to provide an integrated, cost-effective, time efficient end-to-end solution for research and bioproduction to expedite drug development and provide solutions for unmet needs in bioprocessing

January 29, 2018: New name reinforces Pall's commitment to providing standard configurable single-use, stainless steel and hybrid technologies for fed-batch and continuous processes across upstream, downstream and formulation and filling applications in biotech

September 11, 2015: Pall manufacturing facility in Ilfracombe, UK is singled out for its exceptional health and safety management systems

October 20, 2015: A total of four new and updated products to be unveiled at the event, with Pall experts on hand to discuss advances that continuously improve bioprocesses for customers

November 9, 2017: New training courses starting early 2018 focused on continuous bioprocessing advances will detail the state of the industry, and the advantages and practical implications of transitioning from batch to semi- or fully-continuous bioprocess methodologies

December 9, 2016: Cadence Acoustic Separator wins the BioProcess International (BPI) Award for best downstream processing application

July 23, 2018: New partnership to integrate novel biologics and biosimilars process know-how and regulatory experience from molecule selection to full commercialization, with efficient upstream and downstream process equipment and facility design solutions for manufacturers

September 11, 2018: Pall and Aetos partner to combine bioreactors, mixing and storage, and downstream technologies with cell lines and manufacturing processes for expedited biosimilars development

November 14, 2017: New modules enable fully continuous processes in UF/DF processing steps, available in a range of size formats for use in one or more locations of a continuous mAb downstream purification process

June 1, 2021: Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform.

April 1, 2021: Major capacity expansion underway to support increase in industry demand

January 7, 2021: Pall Corporation expands production capacity in the United States and Europe to support industry demand

March 31, 2021: New acquisition will help support single-use technology demand driven by COVID-19

March 19, 2019: New lab will serve as a dedicated platform where the industry can access shared resources including equipment, expertise and project work to find innovative solutions to manufacturing needs for biologic medicines, such as cell-based immunotherapies

April 29, 2019: Freeline's (AAV) manufacturing platform and Pall’s iCELLis bioreactor system combine to achieve commercial-scale and high quality production of AAV gene therapy vectors

September 28, 2016: A series of new product launches being planned for Biotech Week Boston in October

June 15, 2015: Announcing Pall's signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications

October 13, 2016: Introducing a reliable, robust, universal single-use fluid handling connector - a genderless technology for the sterile connection of two fluid paths even in uncontrolled environments